Development -- Yang et al. 130 (23): 5569 Figure IG5

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Regulation of en2 expression and ß-catenin stability by PP2A:B56 ${epsilon}$ in the neural ectoderm at stage 14. (A) RT-PCR showing that en2 is reduced by PP2A:B56 ${epsilon}$ morpholino at stage 14. (B-E) Whole-mount in situ hybridization showing pax2.1 (B,C) and XHR1 (D,E) are not reduced by PP2A:B56 ${epsilon}$ morpholino injection at stage 14. (B,D) Control embryos; (C,E) embryos injected with PP2A:B56 ${epsilon}$ morpholino unilaterally. (F) Western blot showing injected ß-catenin was less stable in the neural ectoderm of PP2A:B56 ${epsilon}$ knockdown embryos. EFGP was used as a control for both injection and loading.